By Michele Maatouk
Date: Tuesday 20 Aug 2024
(Sharecast News) - Johnson & Johnson said on Tuesday that it has agreed to buy V-Wave, a privately-held company focused on developing treatment options for patients with heart failure, for up to $1.7bn.
By Josh White
Date: Wednesday 17 Jul 2024
(Sharecast News) - Johnson & Johnson's stock was in the green on Wednesday, after the pharmaceutical giant reported second-quarter earnings and sales that surpassed analysts' expectations, largely driven by its innovative medicines segment.
By Abigail Townsend
Date: Wednesday 01 May 2024
(Sharecast News) - Johnson & Johnson has proposed a $6.5bn deal to settle thousands of lawsuits claiming its talc products cause cancer, it was confirmed on Wednesday.
Currency | US Dollars |
Share Price | $ 155.50 |
Change Today | $ 2.39 |
% Change | 1.56 % |
52 Week High | $167.38 |
52 Week Low | $144.38 |
Volume | 9,482,439 |
Shares Issued | 2,407.08m |
Market Cap | $374,301m |
RiskGrade | 87 |
Strong Buy | 6 |
Buy | 6 |
Neutral | 12 |
Sell | 0 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
15:59 | 100 @ $155.51 |
15:59 | 100 @ $155.47 |
15:59 | 100 @ $155.47 |
15:59 | 484 @ $155.47 |
15:59 | 200 @ $155.47 |
You are here: research